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Available online 8 August 2019According to theWorld Health Organization (WHO), One Health
is an approach to design and implement programs, policies, legis-
lations, and research in which multiple aspects of the interactions
of humans, animals, food, and the environment are interconnected
(https://www.who.int/features/qa/one-health/en/). These aspects
have a particular relevance for food safety, control of zoonoses and
antibiotic resistance [1e3]. Many microbes can infect or colonize
various compartments forming a complex interplay between
humans, animals and the environment [4]. Efforts focusing on a
single aspect cannot prevent or eliminate the problem. Information
sharing is key and multiple examples exist show-casing this e.g.
drug-resistant bacteria can be transmitted through direct contact
between animals and humans or through the food chain. In order toAll authors have equally contributed to this paper.
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creativecommons.org/licenses/by-nc-nd/4.0/).effectively detect, respond to, and prevent transmission events,
zoonoses and food safety issues, epidemiological and laboratory/
microbiological data have to be shared across stakeholders. Experts
in the fields of microbiology, epidemiology, infectious diseases,
veterinary, and public health should form local, national, regional
and global networks to link the responses of these highly important
public health threats.
A key element in approaching the challenges of One Health in-
cludes generating high resolution spatio-temporal data on patho-
gens together with genomic relatedness of pathogens [5]. Whole
genome sequencing (WGS) has become the new gold standard for
typing and further characterizing of pathogens. WGS enables un-
derstanding transmission chains of bacteria, exchange of mobile
genetic elements, and variation in viruses with the highest reso-
lution. In the near future national and international databases will
allow tracking pathogen transmissions based on WGS data in and
across complex settings such as humans, animals, food, water and
other environmental sources [6e10].1. Participants
The symposium attracted more than 90 participants and faculty
members with a key interest in the fields of One Health and WGS.
The one-day symposium was held on the 21st of May 2019 in
Lucerne, Switzerland, and covered a broad diversity of topics in fourut Pasteur. This is an open access article under the CC BY-NC-ND license (http://
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data sharing, (iii) foodborne pathogens, and (iv) transmissions from
animals and the environment to humans. Finally, in a round table
discussion the requirements and next important steps for “One
Health and sequencing” were addressed. These topics and aspects
were covered by leading experts in their field of One Health, public
health, epidemiology, microbiology, infectious diseases, and ethics.
The workshop was organized and hosted by the Clinical Bacteri-
ology and Mycology of the University Hospital Basel (Dr. Adrian
Egli), Clinical Bacteriology of the University Hospital Geneva (Prof.
Jacques Schrenzel), and the Institute for Food Safety and -Hygiene
of the University of Zurich (Prof. Roger Stephan). The symposium
was sponsored by the National Research Program 72 (www.nrp72.
ch/en). During breaks, therewere opportunities for networking and
fruitful discussions about new ideas and innovative past and future
studies in the field of “One Health”.
2. Session I: perspectives on whole genome sequencing
In the first session of the symposium, perspectives from regu-
latory federal offices (Federal Office of Public Health and Federal
Food Safety and Veterinary Office) were summarized and discussed
by Dr. Koch and Dr. Danuser. Key points included the mindful usage
of new technologies, involvement and interactions with reference
laboratories. In the keynote lecture Prof. Hendriksen addressed the
global connection of animals, food, environment, and humans. He
showcased the power of metagenomic approaches in sewage
samples.
2.1. Federal Food Safety and Veterinary Office FSVO (Jürg Danuser)
The nucleus of One Health is an integrative collaboration of
human and veterinary medicine. Today not only physicians and
vets are One Health agents, but experts from agriculture, food,
environment and other disciplines as well. One Health implies an
agreement between sectors on super ordinated goals and on
measures to be taken. Using a One Health approach, we aim to
generate additional value in terms of better health of humans and
animals, in terms of saving resources and in terms of a positive
impact on the environment. Zoonoses, vector borne diseases,
antimicrobial resistance are main One Health issues. With the
Epidemic act [11] a coordinating platform was established, the so-
called subsidiary body One Health. It coordinates the cooperation
of the concerned sectors in the confederation and the cantons. As
sequencing is a key technology to characterize public and animal
health threads it suits well to the One Health approach.
In the competence of the FSVO sequencing plays or will play an
important role in controlling foodborne diseases, in monitoring of
antimicrobial resistance in food and healthy food producing ani-
mals, and in eradication of epizootic diseases. Introducing WGS
should be coordinated among the stakeholders in different sectors
and with respect to European standards.
2.2. Usage of WGS to address One Health challenges (Rene S.
Hendriksen)
The dynamics of common infectious diseases are changing with
the world heading towards an era of emerging and re-emerging
infectious diseases where antimicrobial resistance threatens the
very core of modern medicine and the sustainability of an effective,
global public health response. Due to the complexity of the prob-
lems, there is a need for a harmonized and immediate action setting
up surveillance.
From a surveillance point of view, sewage as well as animal
wastewater are attractive matrices because it combines materialfrom a large and mostly healthy population, which would other-
wise not be feasible to monitor. Metagenomic sequencing of
sewage and wastewater as well as quantification of antimicrobial
resistance genes and residues combined with epidemiological data
is a possible way to determine the occurrence and burden of
resistance in defined healthy populations.
Recent developments in high-throughput sequencing offer the
ability to rapidly identify nucleic acids from various organisms in
clinical and environmental samples and provide a much broader
resolution than offered by current methodologies. Thus, we
launched a Global Sewage Surveillance study, collecting urban
sewage from 77 cities across 63 countries including all inhabited
continents. Our findings suggest that global AMR gene diversity and
abundance vary by region and are caused by national circum-
stances. Improving sanitation and health could potentially limit the
global burden of antimicrobial resistance [8].
3. Session II: ethics, data protection and data sharing
In the second session of the symposium, various aspects of data
collection, data sharing, and data protection were discussed. Plat-
forms and incentives to share sequence and epidemiological data
were discussed by Dr. Egli and Prof. Neher. Basic and practical as-
pects of data protection and sharing were discussed by Dr. Coman
Schmid. The legal and ethical framework in Switzerland was dis-
cussed by Dr. Driessen.
3.1. Overview on a Swiss pathogen surveillance platform (Adrian
Egli)
Multidrug resistant (MDR) bacteria are one of the most urgent
public health threats for our society. The spread of MDR bacteria
can be described and analyzed using high-resolution molecular
typing technologies, such as WGS. WGS data can be fused with
spatiotemporal epidemiological and demographic patterns thereby
allowing explain transmission events and outbreaks at different
scales [12,13]. However, the data from human, animal, food, and the
environment are fairly complex and often not structured. Interop-
erable and curated epidemiological metadata is a key requirement
to fully understand the “One Health” complexity. In addition, high
quality sequence data is crucial for epidemiological applications.
We aim to build a Swiss wide Surveillance platform to enable the
collection, storage, analysis and interpretation of “classical”
epidemiological data together with molecular epidemiological data
based on WGS from pathogens [5]. The development of the plat-
form is funded by the NRP72 from 2018 to 2020 (www.nrp72.ch)
and we have achieved to develop a first prototype which was
introduced (www.spsp.ch). The platform has a state-of-the-art
backend bioinformatics and frontend visualization tools including
phylogenies, maps and various project management features. After
the proof of concept with methicillin resistant Staphylococcus
aureus, the idea is to expand the platform to a broad spectrum of
pathogens and antibiotic resistant bacteria, including food- and
water-born bacteria and many other pathogens.
3.2. Ethical and legal requirements for surveillance (Susanne
Driessen)
The presentation focused on basic ethical concepts including
deontology and teleology/utilitarianism and links them to the four
bioethical principles beneficence, non-maleficence, justice, and
autonomy. Social benefit, scientific validity, a favorable risk benefit
ratio, as well as an informed consent are additional key ethical
requirements for human research. The basis with the Human
Research Act (HRA; www.swissethics.ch [14]) provides the legal
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projects involving further use of health-related data or biological
material is done. The purpose of the HRA is the protection of dig-
nity, privacy and health of the individuals within research. The
main focus for the One Health approach is the demarcation of
surveillance and bacterial genetics within the HRA: WGS in bac-
terial genetics per se does not fall under the scope of the HRA.
However, whenever there is a linkage to coded health-related data
the HRA applies and consent of the individuals is foreseen. Specific
consent versus general consent apply depending on the hierar-
chism of coding versus anonymization and the implication of ge-
netic versus non-genetic data. Finally, ongoing efforts regarding the
implementation of ethical frameworks in the One Health approach
were discussed.
3.3. Data protection of medical data (Diana Coman Schmid)
Research biomedical data from patients is sensitive personal
data (also referred to as confidential data) and it requires special
data and computing infrastructure services that blend three major
concepts: a) security and compliance, to protect the research sub-
jects' privacy, b) scalability and performance and c) flexibility and
usability, to foster cutting-edge biomedical research.
LeonhardMed (https://sis.id.ethz.ch/), operated by the Scientific
IT Services of ETH Zurich is one of the first such infrastructures
being developed in Switzerland. Built as a security by design
infrastructure, Leonhard Med is a high-performance research
platform to securely store, manage, compute on and share confi-
dential research data and support data driven biomedical research
at ETH and at national level, as part of the emerging national Bio-
MedIT network supporting projects in the Swiss Personalized
Health Network (SPHN; www.sphn.ch).
Using secure IT infrastructures when working with confidential
data requires awareness of data privacy, respective laws, and in-
formation security. When to use such secure infrastructures?
Whenever the research data is confidential. Research data may
classify as confidential (based on the SPHN IT Security Policy [15]
and on the Leonhard Med Acceptable Use Policy) if: (i) it is sensi-
tive personal data (Federal Act on Data Protection, FADP Art. 3c
[16]), for example health-related or medical data, (ii) it is either
identifying (directly or indirectly) or pseudonymized (i.e., real
name replaced by a code), or (iii) more generally, it is information
that is specific to a limited, explicitly defined group of recipients.
However, data classification is not always straightforward. Given
the potential of re-identification [17] should the human gut
microbiome data classify as confidential even though only bacterial
species information is contained?
In the dynamic fields of Precision Medicine, Personalized Health
and One Health, controlled and secure handling and sharing of
confidential data, according to the FAIR principles (Findable
Accessible Interoperable Re-usable), must be embraced for facili-
tating scientific advancement. For this, the pioneering work on
building secure research platforms and developing security
awareness training programs should continue in the collaborative
academic, medical, ELSI and IT ecosystem.
3.4. Incentives for WGS data sharing (Richard Neher)
Detecting outbreaks and transmission clusters requires dense
sampling and the ability to integrate data from different stake-
holders. For such detection of transmission to have impact, it needs
to be timely.
Universal and rapid data sharing of epidemiological and path-
ogen genomic data is therefore imperative. Balancing this need
with privacy concerns and the particular interests of scientists andinstitutions has been a recurring struggle in past outbreaks of vi-
ruses like the West African Ebola virus outbreak [18,19]. Some
communities such as the GenomeTrakr network [20] or the Global
Influenza Response and Surveillance System [21] have successfully
established data sharing mechanisms, while other communities
remain fragmented. Such fragmentation hampers our ability to
combat transmission. The emphasis should be on near universal
open sharing of genome sequences, with meta data restricted
where necessary. Tools and platforms that facilitate tracking of
transmission and integrate data can provide important incentives
for data sharing.
4. Session III: foodborne pathogens
In the third session various examples of foodborne pathogen
transmission were discussed. Dr. M€ausezahl provided an overview
on foodborne pathogens in Switzerlande highlighting the dynamic
changes and the challenges in streamlining the notification process.
This was followed by presentations focusing on Campylobacter spp.
and Salmonella spp. e the two most common bacterial pathogens
associated with gastrointestinal infections in Switzerland by Dr.
Seth-Smith and Dr. Bloemberg. Finally, Prof. Tschudin reported on
the spread of ESBL-producing Enterobacteriaceae and a NRP72
funded project aiming to understand the complex transmission
dynamics.
4.1. Foodborne pathogens in Switzerland (Mirjam M€ausezahl)
The surveillance and control of foodborne pathogens is a classic
One Health topic where interdisciplinary collaboration is key for
success. The surveillance objectives for foodborne diseases in
Switzerland are the early detection and investigation of outbreaks
to identify sources of infection and prevent new infections as well
as the analysis of long-term trends to assess food safety measures
put in place. Notifications of foodborne diseases in humans are
increasing for some pathogens such as Listeria spp., Campylobacter
spp. and Shigatoxin-producing Escherichia coli (STEC) and stay at a
long-term high level for others such as Campylobacter spp. How-
ever, it must be kept in mind that notified cases only represent the
tip of the surveillance pyramid. In addition, the risk for large cross-
border outbreaks increases due to the increasingly globalized food
production and distribution chains. There is a multitude of players
involved in outbreak investigation andmanagement at the national
as well as cantonal level and three different legislative acts (Federal
Act on Epidemics, Foodstuffs and Utility, and Animal epidemics
[11,22,23]) build the basis of all activities. While classical outbreak
investigation involves patient interviewing paired with pathogen
identification and comparison of human and food samples at the
reference laboratory level, WGS enhances microbiological resolu-
tion and the level of “evidence” in case of a match. The main
challenges remain to streamline notification processes and the
matching of isolates between the human and foodstuff sector
including creating the legal framework and to use WGS wisely, as
costs are still relatively high.
4.2. Campylobacter spp. always from chicken to men? (Helena MB
Seth-Smith)
Campylobacter causes a high burden of disease and cost in
Switzerland, and globally [24,25]. The species Campylobacter jejuni
and Campylobacter coli are responsible for the majority of cases.
Cross contamination on kitchen level is thought to be the main
reason for infection, with Multi-Locus Sequence Typing (MLST)
attributing raw chicken as a source in 57e78% of cases [26e30]. Our
study has collected isolates from patients in Basel over four years,
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from potential infection sources: local shop-bought raw chicken,
frozen meat for “fondue chinoise” (broth fondue), river water, pets,
raw milk, and livestock. Our preliminary analysis of 685 genomes,
from patients and chicken meat from 2015e2018, shows a large
diversity of isolates across 24 clonal complexes. We are most
interested in transmission clusters, i.e. patient isolates, which are
closely related to those from chicken meat. To identify these, we
used a hierarchical approach, first clustering isolates using core
genome MLST ([31]; https://pubmlst.org/campylobacter/), then
looking within these clusters using a whole genome single nucle-
otide polymorphism (SNP) approach. Using a SNP cutoff of 12,
which was determined as encompassing the vast majority of cases
and representing a plausible mutation rate across three years, we
can identify 20 transmission clusters including only 14% of cases.
This preliminary work indicates that whole genome studies pro-
vide a much higher resolution than those using MLST, and that
there remain alternative, as yet unidentified infection sources,
potentially responsible for up to 86% of campylobacter cases.
4.3. Outbreak investigation of Salmonella spp. in Switzerland
(Guido Bloemberg)
In Switzerland, approximately 1500 human cases of salmonel-
losis are annually reported to the Federal Office of Human Health
[32]. Salmonella is usually transmitted to humans through
contaminated food or water. Recognition of outbreaks is highly
relevant for source identification and effective containment (incl.
product recalls). Up to 2018, Salmonella outbreaks were monitored
using PFGE analysis of suspicious outbreak isolates. During 2018,
WGS, as most discriminative typing tool, was implemented for
Salmonella outbreak analyses. Meanwhile, several Salmonella out-
breaks have been discovered, are being monitored or/and were
solved by WGS analysis. In the presentation five examples of Sal-
monella outbreak analyses were presented. Two small outbreaks of
S. Typhi (family outbreak after visiting Bangladesh) and S. Paratyphi
B var. Java (4 patients) were identified in 2018 and 2019, respec-
tively. Furthermore, S. Enteritidis cases identified during
JulyeSeptember 2018 were systematically analyzed by WGS in or-
der to analyze the clonality of the isolates. The results showed a
large diversity of S. Enteritidis strains with only a few small out-
breaks and travel as main risk factor. Lastly, we are monitoring two
ongoing outbreaks of S. München (38 patients) and S. Derby (20
patients) occurring since December 2018 and January 2019,
respectively.
4.4. Transmission of ESBL-producing E. coli in Basel (Sarah
Tschudin-Sutter)
Community reservoirs have been suggested as being an
important driver for the rapid emergence and spread of ESBL-
producing E. coli. The food chain may represent a potential
community-source with over 90% of chicken meat being contami-
natedwith ESBL-producing E. coli [33,34] and almost 20% of healthy
Swiss fattening pigs are shedding ESBL-producing E. coli [35]. 39%
of ESBL-producing isolates detected in retail meat samples
belonged to E. coli genotypes also present in human samples sug-
gesting transmission [34]. ESBL-producing E. coli has been identi-
fied on 12% of cutting boards and 50% of gloves after poultry
preparation, pointing to a potential transmission-pathway [36].
Both human and animal intestinal carriage of ESBL-producing
Enterobacteriaceae result in their release into the wastewater sys-
tem. ESBL-producing E. coli have been recently identified in almost
all environmental samples collected throughout a wastewater
network in France, with treatment at the wastewater plantresulting in a relative enrichment of ESBL-producing E. coli in the
sludge, which is consecutively used as fertilizer [37] thereby
accelerating further dissemination. In Basel, we are currently
determining migration of ESBL-producing Enterobacteriaceae be-
tween humans and their environment (i.e. foodstuffs and waste-
water samples) by comparing genetic relatedness of strains
recovered from patients and the environment as part of a NRP72
research project (http://www.nfp72.ch/) [38].
5. Session IV: transmissions from the environmental and
animals to humans
In the fourth session various examples of environmental and
zoonotic pathogen transmission were discussed. First, Prof. Endi-
miani reported on the current situation of Carbapenem resistant
Enterobacteriaceae and a NRP72 project, which aims to understand
the transmission dynamics of Carbapenemase-producing Entero-
bacteriaceae. Then, Prof. Perreten reported on increasing cases of
Carbapenemase-producing Enterobacteriaceae found in pets. Next,
Prof. Schrenzel focused on new technologies e using metagenomic
approachese and showcased the impact of this technology in three
cases from clinics. Finally, Prof. Greub reported on the genomics of
Chlamydia-related bacteria.
5.1. Carbapenemase-producing Enterobacteriaceae in humans
(Andrea Endimiani)
The prevalence of carbapenem-resistant Klebsiella pneumoniae
and E. coli strains in Europe reached 7.2% and 0.1%, respectively;
however, only 50e60% of them produce carbapenemases (CPE).
Most of the CPE responsible for community-onset infection are
actually health-care associated. This phenomenon may contribute
to the expansion of CPE in the community. In Switzerland, 1.8% of
the human K. pneumoniae isolates are carbapenem resistant. Until
2018, CPEwere not reported in pets, wild/food animals, and retailed
meat. Moreover, CPE were not isolated in healthy people, but
sporadic strains were reported in returning travelers, rivers/lakes,
and imported vegetables.
During the first year of our NRP72 project, we analyzed 29
carbapenem-resistant Enterobacteriaceae of human origin using
WGS. Strains were from hospital and community settings and
causing infection or colonization. Of particular interest is the
finding that veterinary clinic employees can be colonized at gut
level with the same CPE (OXA-181-producing E. coli ST410)
responsible for an outbreak among hospitalized pets. Moreover, at
national level OXA-181 producers are increasing; therefore, an ac-
curate WGS analysis is ongoing for different species carrying such
resistance gene. The final aim of our work is to analyze the ex-
change of MDR organisms and/or plasmids among the different
human and non-human settings.
5.2. Carbapenemase-producing Enterobacteriaceae in animals
(Vincent Perreten)
Carbapenems are not used in food-producing animals in
Switzerland. However, these last-line antibiotics of human medi-
cine may be used in companion animals for the treatment of in-
fections refractory to any other antibiotics used in veterinary
medicine (Ordinance on Veterinary Medicinal Products, SR
812.212.27, Art. 6, [39]). NGS used during a surveillance project
financed by the Swiss Federal Food Safety and Veterinary Office
[FSVO Grant no. 1.18.10]a revealed the presence of a nosocomial
clone of E. coli containing a plasmid-mediated carbapenemase.
Additionally, cases of infections caused by carbapenemase-
producing K. pneumoniae have also emerged in our country in
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specific carbapenemase-producing clones, further additional mo-
lecular epidemiology studies are now necessary to determine the
link between the carbapenemase-producing Enterobacteriaceae
from companion animals and those from humans. Nevertheless,
infection control and monitoring of carbapenemase-producing
Enterobacteriaceae should be introduced in veterinary settings.
aFSVO project no. 1.18.10 (Simone Schuller, Department of Clin-
ical Veterinary Medicine, University of Bern, Bern, Switzerland;
Barbara Willi, Clinic for Small Animal Internal Medicine, University
of Zurich, Zurich, Switzerland; Stefan Kuster, Division of Infectious
Diseases and Hospital Epidemiology, University and University
Hospital of Zurich, Faculty of Medicine, Zurich, Switzerland; Andrea
Endimiani, Institute for Infectious Diseases, University of Bern,
Bern, Switzerland; Stefanie Gobeli and Vincent Perreten, Institute
of Veterinary Bacteriology, University of Bern, Bern, Switzerland).
5.3. Unusual zoonoses: the contribution of NGS (Jacques Schrenzel)
In some instances, the infectious source of severely infected
patients remains unknown, prompting the physician to perform
numerous tests, including radiological investigations. We report
two such cases: the first one was a bacteremia due to an unusual
Capnocytophaga canis, most likely transmitted from the patient's
cat. Genomics revealed that this bacteriumwas distantly related to
Capnocytophaga canimorsus, and hence could not be detected by
MALDI-TOF MS. The second case was a septic shock with multiple
organ failure due to Streptococcus suis. Genomic analysis revealed
that the strain was markedly different from those recovered from
Swiss pigs. The history of the patient ultimately revealed that she
had eaten raw pork imported from Moldavia, two days before
admission. The last case, analyzed by our metagenomic platform
showed a prosthetic aortic infection due to Mycobacterium chelo-
nae, an organism that could not be detected by conventional cul-
tures nor by broad-range 16S rDNA PCR. The origin of the infectious
organism and its relationship with the bovine aortic prosthesis are
currently under investigation. Overall, these three cases illustrate
various usages of genomics and clinical metagenomics to uncover
bacterial causes of some infections and provide molecular hints to
explain their acquisition.
5.4. Genomics of chlamydia-related bacteria (Gilbert Greub)
In the last talk of the day, Prof Greub (Lausanne) presented the
lessons gathered from 20 years of genomics of chlamydia and
chlamydia-related bacteria. Chlamydia are important zoonotic and
veterinary pathogens. Indeed, although Chlamydia trachomatis e
the most studied member of the Chlamydiales order e is sexually
transmitted from human to human, Chlamydia psittaci is a well-
established pathogen transmitted from birds to humans, which
has recently been identified in horses as well [40]. Chlamydia
abortus, a major cause of abortion in sheep and goats e has been
shown to cause miscarriage in humans exposed to infected cattles.
Thus, genomics may be pivotal to track outbreaks and to define the
virulome and resistome of chlamydiae. The Greub's talk however
showed that genomics may go behind typing, virulome and resis-
tome analyses, providing insight on the evolution, biology and
biodiversity of chlamydia-related bacteria. The metagenomics data
that have been recently released demonstrates the huge biodiver-
sity of Chlamydiales bacteria [41]. This biodiversity reflects the
variety of ecological niches, which include amoebae (e.g. Para-
chlamydia, Criblamydia, Estrella), mammals (e.g. Chlamydia felis,
Chlamydia abortus, Waddlia), fish (e.g. Clavochlamydiaceae, Pisci-
chlamydiaceae), birds (e.g. C. psitacci, C. ibidis), reptiles (e.g. Para-
chlamydia), and arthropods (e.g. Rhabdochlamydiaceae). The latterfamily infects ticks with very high burden, suggesting a high
transmission risk. Genomics of all these new clades led to identify
interesting features, not present in C. trachomatis, including a
CRISPR system (in Protochlamydia neagleriophila), large number of
transposases (especially inWaddlia) and a DNA conjugative transfer
system (in various chlamydia-related bacteria) demonstrating the
high genetic plasticity of chlamydial genomes. Genomics of
chlamydia-related bacteria also highlighted the conservation
among all Chlamydiales of some virulence factors, involved in cell
host corruption (e.g. T3SS system, CPAF) and the presence of spe-
cific virulence factors such as catalases in some species, likely
implicated in the survival of these strict intracellular bacteria to the
superoxydes produced by amoebae and macrophages.
6. Discussions and conclusions
The symposium brought together “One Health” leaders from
Switzerland representing various backgrounds including federal
offices with public health experts, legal and ethical experts, mi-
crobiologists, infectious disease specialists, and epidemiologists.
Next generation sequencing technologies were broadly discussed
along with concrete cases from clinics and applied and basic
research showing the potential to gain a more profound under-
standing of transmission routes between humans, animals, food,
and the environment.
Although new sequencing technologies and applications such as
metagenomics rapidly move forward in research, the usage of these
technologies for public health aspects was still somewhat contro-
versial discussed in the presence of all stakeholders. Without
doubt, today WGS provides the highest possible resolution for
typing pathogens for either surveillance or single outbreak in-
vestigations. However, the usage of the technology in public health
and routine diagnostics is still associated with high costs and re-
quires specific trained experts such as bioinformaticians, for proper
data interpretation. In addition, the full potential of the technology
is not yet used: while comparison of pathogens is standard, infor-
mation on resistance genes and virulence factors is often not
generated due to lack of curated and standardized databases.
Finally, the gain of resolution using WGS can provide “unexpected”
results, where certain isolates may appear connected (or uncon-
nected) supporting or refuting classical epidemiological typing.
This raises the question of how to best combine whole genome
sequencing datawith data on epidemiological observations to draw
meaningful conclusions regarding the dissemination and spread of
target pathogens e maybe even allowing to establish causal infer-
ence. These discussions underline our recent exposure to these new
technologies, while our background remains tightly linked to
classical epidemiological tools. The expectation on what
sequencing should deliver in the near future and how such results
might impact public health actions somewhat vary between federal
institutions and the diagnostic community. The discussions high-
lighted two possible scenarios for epidemiological analysis:
(i) Use ofWGS to confirm an outbreak. A (pre-)selected group of
isolates with available classical epidemiological data e.g.
symptoms, exposure, time and space association of isolates
etc. are analyzed retrospectively using a high-resolution
method. Such very targeted usage and potential batch-wise
sequencing analyses provide a high cost-efficiency. Howev-
er, non-outbreak associated controls are also important in
outbreak investigations, allowing to make comparison to
groups and allow to calculate odds ratios, which remain the
main factor of causal inference. The obvious disadvantage is
the introduction of a clear bias due to the selection of cases,
which may hinder broader conclusion on the “big picture”.
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based on similar antibiotic resistance profiles, WGS typing
can be rapidly introduced, in other public health settings a
delay in producing sequencing may results may be intro-
duced due to a more complex reporting between various
institutions.
(ii) Use of WGS as a real-time surveillance tool. Isolates are
sequenced immediately, in a less biased way, and directly
grouped based on genomic similarities. Based on molecular
evidence, a detailed classical epidemiological investigation
may be triggered. This approach may be particular useful
when unsuspected molecular epidemiological links are
discovered and are then followed up using classical epide-
miological approaches. This strategy may result in significant
faster responses for the identification of connected cases.
However, at least for the coming years, this approach incurs
higher costs as many more isolates would need to be
sequenced.
Both approaches have obvious advantages and disadvantages,
which need to be further explored with investigations on specific
scenarios and pathogens. For our community, it is therefore crucial
to learn from these new technologies, not only in tightly controlled
experimental research conditions, but also in the real-world of
public health. Both approaches need to be explored and tested in
different scenarios and order to define the specific advantages.
Independently of which approach is preferred, the distribution of
molecular and epidemiological information to laboratories, policy
makers, and public health experts is essential.
Data access and sharing, especially of demographic and epide-
miological data, is often critical in order to use the synergistic po-
tential of classical and molecular epidemiology. In this regard,
regulations, legal and ethical considerations were discussed. The
experts agreed that public health questions may be complex and
sometimes there are overlaps between public health and research
objectives. In order to understand the impact of a new technology,
data has to be analyzed using state-of-the-art research methodol-
ogies. Public health investigations benefit from timely reporting
and dissemination of results e classically this is performed on data
from mandatory notification (high sensitivity, but low specificity
for an outbreak) e however given current technological advances
sequencing information is now expected to provide highly specific
data. Molecular surveillance also provides a high sensitivity in
contrast to targeted outbreak investigation. Pragmatic solutions
should be developed for the sharing of classical and molecular
epidemiology information by carefully addressing the special needs
of the different stakeholders. The legal framework provides the
basis for what information can be shared in which situation. The
epidemic act provides the legal basis to share information at the
governmental level (federal and cantonal) but not with the private
sector, which induces a series of practical challenges for manage-
ment of transmission events. In the case of an immediate public
health threat e.g. a new pandemic influenza virus, the epidemio-
logical act provides a more clear legal basis. Although also research
can be performed under the epidemic act, the separation to the
human research act has to be further discussed with legal and
public health experts. Whereas in the case of a research related
question, the Human Research Act constitutes the legal basis.
In summary, it became clear, that the various experts attending
symposium are keen and highly motivated to further develop the
concepts and knowledge on sequencing for public health and One
Health. In a small country like Switzerland, the development of a
molecular surveillance platform integrating the different needs and
aspects of the identified stakeholders can be developed in as a
research project and later scaled up to fit various needs withincreasing complexity such as specific public health needs. The
symposium clearly showed that the state-of-the-art infrastructure
e.g. sequencing machines, computational clusters, the bio-
informatic, legal and ethical expertise for a responsible usage of the
technologies is in place. Several research projects showcased the
feasibility and the potential impact, as well as the benefits for
humans, animals and the environment. What is now needed is the
willingness and the political support to fill the gaps and scale up.
Conflict of interest
None of the authors have a conflict of interest.
Acknowledgements
The symposium was funded by the Swiss National Science
Foundation e NRP72 on antibiotic resistance.
References
[1] Antao EM, Vincze S, Hanke R, Klimmek L, Suchecka K, Lubke-Becker A, et al.
Antibiotic resistance, the 3As and the road ahead. Gut Pathog 2018;10:52.
[2] Berger KM, Wood JLN, Jenkins B, Olsen J, Morse SS, Gresham L, et al. Policy and
science for global health security: shaping the course of international health.
Trop Med Infect Dis 2019;4:E60.
[3] Garcia SN, Osburn BI, Cullor JS. A one health perspective on dairy production
and dairy food safety. One Health 2019;7:100086.
[4] Trinh P, Zaneveld JR, Safranek S, Rabinowitz PM. One health relationships
between human, animal, and environmental microbiomes: a mini-review.
Front Public Health 2018;6:235.
[5] Egli A, Blanc DS, Greub G, Keller PM, Lazarevic V, Lebrand A, et al. Improving
the quality and workflow of bacterial genome sequencing and analysis:
paving the way for a Switzerland-wide molecular epidemiological surveil-
lance platform. Swiss Med Wkly 2018;148:w14693.
[6] Brilhante M, Perreten V, Dona V. Multidrug resistance and multivirulence
plasmids in enterotoxigenic and hybrid Shiga toxin-producing/
enterotoxigenic Escherichia coli isolated from diarrheic pigs in Switzerland.
Vet J 2019;244:60e8.
[7] Dona V, Bernasconi OJ, Pires J, Collaud A, Overesch G, Ramette A, et al. Het-
erogeneous genetic location of mcr-1 in colistin-resistant Escherichia coli
isolates from humans and retail chicken meat in Switzerland: emergence of
mcr-1-carrying IncK2 plasmids. Antimicrob Agents Chemother 2017:61.
[8] Hendriksen RS, Munk P, Njage P, van Bunnik B, McNally L, Lukjancenko O,
et al. Global monitoring of antimicrobial resistance based on metagenomics
analyses of urban sewage. Nat Commun 2019;10:1124.
[9] Piso RJ, Kach R, Pop R, Zillig D, Schibli U, Bassetti S, et al. A cross-sectional
study of colonization rates with methicillin-resistant Staphylococcus aureus
(MRSA) and extended-spectrum beta-lactamase (ESBL) and carbapenemase-
producing Enterobacteriaceae in four Swiss refugee centres. PLoS One
2017;12:e0170251.
[10] Wuthrich D, Gautsch S, Spieler-Denz R, Dubuis O, Gaia V, Moran-Gilad J, et al.
Air-conditioner cooling towers as complex reservoirs and continuous source
of Legionella pneumophila infection evidenced by a genomic analysis study in
2017, Switzerland. Euro Surveill 2019:24.
[11] Federal Office of Public Health F. Communicable diseases legislation - epi-




[12] Nadon C, Van Walle I, Gerner-Smidt P, Campos J, Chinen I, Concepcion-
Acevedo J, et al. PulseNet International: vision for the implementation of
whole genome sequencing (WGS) for global food-borne disease surveillance.
Euro Surveill 2017;22.
[13] Sanaa M, Pouillot R, Vega FG, Strain E, Van Doren JM. GenomeGraphR: a user-
friendly open-source web application for foodborne pathogen whole genome
sequencing data integration, analysis, and visualization. PLoS One 2019;14:
e0213039.
[14] Council Tf. Federal act on research involving human beings. The federal
Council; 2014 [cited 2019 24.06.2019]. Available from: www.admin.ch.
https://www.admin.ch/opc/en/classified-compilation/20061313/index.html.
[15] Network SPH. SPHN information security policy. Swiss Personalized Health
Network; 2018. p. 21. https://www.sphn.ch/en/about/publications.html.
[16] Council Tf. Federal act on data protection. The federal Council; 2019 (updated
01.03.2019; cited 2019 24.06.2019). Available from: https://www.admin.ch/
opc/en/classified-compilation/19920153/index.html.
[17] Franzosa EA, Huang K, Meadow JF, Gevers D, Lemon KP, Bohannan BJ, et al.
Identifying personal microbiomes using metagenomic codes. Proc Natl Acad
Sci U S A 2015;112:E2930e8.
A. Egli et al. / Microbes and Infection 22 (2020) 1e7 7[18] D'Agostino M, Samuel NO, Sarol MJ, de Cosio FG, Marti M, Luo T, et al. Open
data and public health. Rev Panam Salud Públic 2018;42:e66.
[19] Royo-Bordonada MA, Garcia Lopez FJ. Ethical considerations surrounding the
response to Ebola: the Spanish experience. BMC Med Ethics 2016;17:49.
[20] Timme RE, Sanchez Leon M, Allard MW. Utilizing the public GenomeTrakr
database for foodborne pathogen traceback. Methods Mol Biol 2019;1918:
201e12.
[21] Hay AJ, McCauley JW. The WHO global influenza surveillance and response
system (GISRS)-A future perspective. Influenza Other Respir Viruses; 2018.
https://doi.org/10.1111/irv.12565 [Epub ahead of print)].
[22] Council Tf. Federal act on foodstuffs and utility articles: the federal council.
2017 (updated 01.05.2017; cited 2019 24.06.2019). Available from: https://
www.admin.ch/opc/en/classified-compilation/20101912/index.html.
[23] Council Tf. Tierseuchengesetz: the federal council. 2019 (updated 01.05.2017;
cited 2019 24.06.2019). Available from: https://www.admin.ch/opc/de/
classified-compilation/19660145/index.html.
[24] Li M, Havelaar AH, Hoffmann S, Hald T, Kirk MD, Torgerson PR, et al. Global
disease burden of pathogens in animal source foods, 2010. PLoS One 2019;14:
e0216545.
[25] Schmutz C, Mausezahl D. The burden of gastroenteritis in Switzerland (BUGS)
study: a research proposal for a 1-year, prospective cohort study. BMC Res
Notes 2018;11:816.
[26] Kittl S, Heckel G, Korczak BM, Kuhnert P. Source attribution of human
Campylobacter isolates by MLST and fla-typing and association of genotypes
with quinolone resistance. PLoS One 2013;8:e81796.
[27] Mughini Gras L, Smid JH, Wagenaar JA, de Boer AG, Havelaar AH, Friesema IH,
et al. Risk factors for campylobacteriosis of chicken, ruminant, and environ-
mental origin: a combined case-control and source attribution analysis. PLoS
One 2012;7:e42599.
[28] Mullner P, Spencer SE, Wilson DJ, Jones G, Noble AD, Midwinter AC, et al.
Assigning the source of human campylobacteriosis in New Zealand: a
comparative genetic and epidemiological approach. Infect Genet Evol 2009;9:
1311e9.
[29] Sheppard SK, Dallas JF, Strachan NJ, MacRae M, McCarthy ND, Wilson DJ, et al.
Campylobacter genotyping to determine the source of human infection. Clin
Infect Dis 2009;48:1072e8.
[30] Wilson DJ, Gabriel E, Leatherbarrow AJ, Cheesbrough J, Gee S, Bolton E, et al.
Tracing the source of campylobacteriosis. PLoS Genet 2008;4:e1000203.[31] Cody AJ, Bray JE, Jolley KA, McCarthy ND, Maiden MCJ. Core genome multi-
locus sequence typing scheme for stable, comparative analyses of Campylo-
bacter jejuni and C. coli human disease isolates. J Clin Microbiol 2017;55:
2086e97.
[32] Bless PJ, Schmutz C, Sartori K, Mausezahl D. Time trends of positivity rates
from foodborne pathogen testing in Switzerland, 2003 to 2012. Swiss Med
Wkly 2017;147:w14569.
[33] Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, et al.
Extended-spectrum beta-lactamase genes of Escherichia coli in chicken meat
and humans, The Netherlands. Emerg Infect Dis 2011;17:1216e22.
[34] Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den
Munckhof MP, van Essen-Zandbergen A, et al. Dutch patients, retail chicken
meat and poultry share the same ESBL genes, plasmids and strains. Clin
Microbiol Infect 2011;17:873e80.
[35] Geser N, Stephan R, Kuhnert P, Zbinden R, Kaeppeli U, Cernela N, et al. Fecal
carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae
in swine and cattle at slaughter in Switzerland. J Food Prot 2011;74:446e9.
[36] Tschudin-Sutter S, Frei R, Stephan R, Hachler H, Nogarth D, Widmer AF.
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: a
threat from the kitchen. Infect Control Hosp Epidemiol 2014;35:581e4.
[37] Brechet C, Plantin J, Sauget M, Thouverez M, Talon D, Cholley P, et al.
Wastewater treatment plants release large amounts of extended-spectrum
beta-lactamase-producing Escherichia coli into the environment. Clin Infect
Dis 2014;58:1658e65.
[38] Stadler T, Meinel D, Aguilar-Bultet L, Huisman JS, Schindler R, Egli A, et al.
Transmission of ESBL-producing Enterobacteriaceae and their mobile genetic
elements-identification of sources by whole genome sequencing: study pro-
tocol for an observational study in Switzerland. BMJ Open 2018;8:e021823.
[39] Council Tf. Verordnung über die Tierarzneimittel: the federal Council. 2019
(updated 01.01.2019; cited 2019 24.06.2019). Available from: https://www.
admin.ch/opc/de/classified-compilation/20030705/index.html.
[40] Polkinghorne A, Greub G. A new equine and zoonotic threat emerges from
an old avian pathogen, Chlamydia psittaci. Clin Microbiol Infect 2017;23:
693e4.
[41] Pillonel T, Bertelli C, Greub G. Environmental metagenomic assemblies reveal
seven new highly divergent chlamydial lineages and hallmarks of a conserved
intracellular lifestyle. Front Microbiol 2018;9:79.
